{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:52:42Z","timestamp":1791492762977,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00415-024-12734-1","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T12:22:30Z","timestamp":1734006150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["What is the future for dementia with Lewy bodies?"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0544-8384","authenticated-orcid":false,"given":"Bianca","family":"Palushaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J. G.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Abdelnour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"issue":"4","key":"12734_CR1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/S0033291713000494","volume":"44","author":"SA Vann Jones","year":"2014","unstructured":"Vann Jones SA, O\u2019Brien JT (2014) The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med 44(4):673\u2013683","journal-title":"Psychol Med"},{"issue":"2","key":"12734_CR2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3233\/JAD-131856","volume":"41","author":"S Garcia-Ptacek","year":"2014","unstructured":"Garcia-Ptacek S et al (2014) Mortality risk after dementia diagnosis by dementia type and underlying factors: a cohort of 15,209 patients based on the Swedish Dementia Registry. J Alzheimers Dis 41(2):467\u2013477","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"12734_CR3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S1474-4422(17)30074-1","volume":"16","author":"C Mueller","year":"2017","unstructured":"Mueller C et al (2017) The prognosis of dementia with Lewy bodies. Lancet Neurol 16(5):390\u2013398","journal-title":"Lancet Neurol"},{"key":"12734_CR4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.dadm.2017.12.001","volume":"10","author":"C Mueller","year":"2018","unstructured":"Mueller C et al (2018) Hospitalization in people with dementia with Lewy bodies: frequency, duration, and cost implications. Alzheimers Dement (Amst) 10:143\u2013152","journal-title":"Alzheimers Dement (Amst)"},{"issue":"3\u20134","key":"12734_CR5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000358051","volume":"38","author":"R Oesterhus","year":"2014","unstructured":"Oesterhus R et al (2014) Long-term mortality in a cohort of home-dwelling elderly with mild Alzheimer\u2019s disease and Lewy body dementia. Dement Geriatr Cogn Disord 38(3\u20134):161\u2013169","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"11","key":"12734_CR6","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1212\/01.wnl.0000247041.63081.98","volume":"67","author":"MM Williams","year":"2006","unstructured":"Williams MM et al (2006) Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease. Neurology 67(11):1935\u20131941","journal-title":"Neurology"},{"issue":"4","key":"12734_CR7","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2020.44","volume":"6","author":"A Surendranathan","year":"2020","unstructured":"Surendranathan A et al (2020) Clinical diagnosis of Lewy body dementia. BJPsych Open 6(4):e61","journal-title":"BJPsych Open"},{"issue":"4","key":"12734_CR8","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3233\/JAD-231177","volume":"97","author":"MJ Armstrong","year":"2024","unstructured":"Armstrong MJ, Barnes LL (2024) Under-diagnosis of dementia with Lewy bodies in individuals racialized as black: hypotheses regarding potential contributors. J Alzheimers Dis 97(4):1571\u20131580","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"12734_CR9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/alz.12814","volume":"19","author":"JB Toledo","year":"2023","unstructured":"Toledo JB et al (2023) Dementia with Lewy bodies: impact of co-pathologies and implications for clinical trial design. Alzheimers Dement 19(1):318\u2013332","journal-title":"Alzheimers Dement"},{"key":"12734_CR10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.parkreldis.2020.09.030","volume":"80","author":"KS Chin","year":"2020","unstructured":"Chin KS et al (2020) Prevalence and clinical associations of tau in Lewy body dementias: a systematic review and meta-analysis. Parkinsonism Relat Disord 80:184\u2013193","journal-title":"Parkinsonism Relat Disord"},{"key":"12734_CR11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s40120-023-00467-8","volume":"12","author":"C Abdelnour","year":"2023","unstructured":"Abdelnour C et al (2023) Dementia with Lewy bodies drug therapies in clinical trials: systematic review up to 2022. Neurol Ther 12:727\u2013749","journal-title":"Neurol Ther"},{"issue":"1","key":"12734_CR12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40035-022-00299-w","volume":"11","author":"F Rodriguez-Porcel","year":"2022","unstructured":"Rodriguez-Porcel F et al (2022) Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations. Transl Neurodegener 11(1):24","journal-title":"Transl Neurodegener"},{"issue":"1","key":"12734_CR13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"I McKeith","year":"2017","unstructured":"McKeith I et al (2017) Diagnosis and managament of dementia with Lewy bodies. Neurology 89(1):88\u2013100","journal-title":"Neurology"},{"issue":"17","key":"12734_CR14","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","volume":"94","author":"IG McKeith","year":"2020","unstructured":"McKeith IG et al (2020) Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology 94(17):743\u2013755","journal-title":"Neurology"},{"issue":"1","key":"12734_CR15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-0043-1764204","volume":"43","author":"C Abdelnour","year":"2023","unstructured":"Abdelnour C, Poston KL (2023) Cognitive impairment in neurodegenerative movement disorders. Semin Neurol 43(1):81\u201394","journal-title":"Semin Neurol"},{"issue":"3","key":"12734_CR16","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s40120-024-00620-x","volume":"13","author":"KA Wyman-Chick","year":"2024","unstructured":"Wyman-Chick KA et al (2024) Differentiating prodromal dementia with Lewy bodies from prodromal Alzheimer\u2019s disease: a pragmatic review for clinicians. Neurol Ther 13(3):885\u2013906","journal-title":"Neurol Ther"},{"issue":"5","key":"12734_CR17","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s00134-019-05907-4","volume":"46","author":"AJC Slooter","year":"2020","unstructured":"Slooter AJC et al (2020) Updated nomenclature of delirium and acute encephalopathy: statement of ten societies. Intensive Care Med 46(5):1020\u20131022","journal-title":"Intensive Care Med"},{"issue":"1","key":"12734_CR18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s00415-023-12000-w","volume":"271","author":"CW Gunawardana","year":"2024","unstructured":"Gunawardana CW, Matar E, Lewis SJG (2024) The clinical phenotype of psychiatric-onset prodromal dementia with Lewy bodies: a scoping review. J Neurol 271(1):606\u2013617","journal-title":"J Neurol"},{"issue":"5","key":"12734_CR19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf A et al (2023) Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using alpha-synuclein seed amplification: a cross-sectional study. Lancet Neurol 22(5):407\u2013417","journal-title":"Lancet Neurol"},{"issue":"1","key":"12734_CR20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s40478-021-01282-8","volume":"9","author":"MJ Russo","year":"2021","unstructured":"Russo MJ et al (2021) High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson\u2019s disease. Acta Neuropathol Commun 9(1):179","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"12734_CR21","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ana.26453","volume":"92","author":"MR Arnold","year":"2022","unstructured":"Arnold MR et al (2022) Alpha-synuclein seed amplification in CSF and brain from patients with different brain distributions of pathological alpha-synuclein in the context of co-pathology and non-LBD diagnoses. Ann Neurol 92(4):650\u2013662","journal-title":"Ann Neurol"},{"issue":"6","key":"12734_CR22","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/s41591-023-02358-9","volume":"29","author":"A Okuzumi","year":"2023","unstructured":"Okuzumi A et al (2023) Propagative alpha-synuclein seeds as serum biomarkers for synucleinopathies. Nat Med 29(6):1448\u20131455","journal-title":"Nat Med"},{"issue":"1","key":"12734_CR23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41531-023-00627-5","volume":"10","author":"K Brockmann","year":"2024","unstructured":"Brockmann K et al (2024) CSF alpha-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson\u2019s disease. NPJ Parkinsons Dis 10(1):24","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"12734_CR24","doi-asserted-by":"crossref","first-page":"6750","DOI":"10.1038\/s41467-023-42305-3","volume":"14","author":"R Smith","year":"2023","unstructured":"Smith R et al (2023) The alpha-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases. Nat Commun 14(1):6750","journal-title":"Nat Commun"},{"issue":"15","key":"12734_CR25","doi-asserted-by":"crossref","first-page":"2540 e8","DOI":"10.1016\/j.neuron.2024.05.006","volume":"112","author":"H Endo","year":"2024","unstructured":"Endo H et al (2024) Imaging alpha-synuclein pathologies in animal models and patients with Parkinson\u2019s and related diseases. Neuron 112(15):2540 e8-2557 e8","journal-title":"Neuron"},{"issue":"7825","key":"12734_CR26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","volume":"585","author":"M Schweighauser","year":"2020","unstructured":"Schweighauser M et al (2020) Structures of alpha-synuclein filaments from multiple system atrophy. Nature 585(7825):464\u2013469","journal-title":"Nature"},{"key":"12734_CR27","doi-asserted-by":"crossref","unstructured":"Kannarkat GT et al (2024) Alpha-synuclein conformations in plasma distinguish parkinson's disease from dementia with Lewy bodies. bioRxiv","DOI":"10.1101\/2024.05.07.593056"},{"issue":"1","key":"12734_CR28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41531-023-00604-y","volume":"9","author":"MF Altay","year":"2023","unstructured":"Altay MF et al (2023) Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases. NPJ Parkinsons Dis 9(1):161","journal-title":"NPJ Parkinsons Dis"},{"key":"12734_CR29","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/s43587-023-00478-y","volume":"3","author":"JB Pereira","year":"2023","unstructured":"Pereira JB et al (2023) DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease. Nat Aging 3:1201\u20131209","journal-title":"Nat Aging"},{"issue":"10","key":"12734_CR30","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/s43587-023-00478-y","volume":"3","author":"JB Pereira","year":"2023","unstructured":"Pereira JB et al (2023) DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease. Nat Aging 3(10):1201\u20131209","journal-title":"Nat Aging"},{"issue":"1","key":"12734_CR31","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1038\/s41467-024-47027-8","volume":"15","author":"TM Goralski","year":"2024","unstructured":"Goralski TM et al (2024) Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology. Nat Commun 15(1):2642","journal-title":"Nat Commun"},{"issue":"3","key":"12734_CR32","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.0000000000003512","volume":"88","author":"AJ Thomas","year":"2017","unstructured":"Thomas AJ et al (2017) Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Neurology 88(3):276\u2013283","journal-title":"Neurology"},{"issue":"1","key":"12734_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14802\/jmd.19052","volume":"13","author":"M Yamada","year":"2020","unstructured":"Yamada M et al (2020) Diagnostic criteria for dementia with lewy bodies: updates and future directions. J Mov Disord 13(1):1\u201310","journal-title":"J Mov Disord"},{"issue":"3","key":"12734_CR34","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","volume":"53","author":"R Chia","year":"2021","unstructured":"Chia R et al (2021) Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat Genet 53(3):294\u2013303","journal-title":"Nat Genet"},{"issue":"9","key":"12734_CR35","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/brain\/awad150","volume":"146","author":"P Calabresi","year":"2023","unstructured":"Calabresi P et al (2023) Advances in understanding the function of alpha-synuclein: implications for Parkinson\u2019s disease. Brain 146(9):3587\u20133597","journal-title":"Brain"},{"issue":"2","key":"12734_CR36","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni T et al (2024) A biological definition of neuronal alpha-synuclein disease: towards an integrated staging system for research. Lancet Neurol 23(2):178\u2013190","journal-title":"Lancet Neurol"},{"issue":"2","key":"12734_CR37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","volume":"23","author":"GU Hoglinger","year":"2024","unstructured":"Hoglinger GU et al (2024) A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol 23(2):191\u2013204","journal-title":"Lancet Neurol"},{"key":"12734_CR38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-030-05542-4_2","volume":"1118","author":"J Cummings","year":"2019","unstructured":"Cummings J (2019) The role of biomarkers in Alzheimer\u2019s disease drug development. Adv Exp Med Biol 1118:29\u201361","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"12734_CR39","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1474-4422(23)00283-1","volume":"22","author":"M Rizig","year":"2023","unstructured":"Rizig M et al (2023) Identification of genetic risk loci and causal insights associated with Parkinson\u2019s disease in African and African admixed populations: a genome-wide association study. Lancet Neurol 22(11):1015\u20131025","journal-title":"Lancet Neurol"},{"issue":"4","key":"12734_CR40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3233\/JPD-012138","volume":"2","author":"NM Kanaan","year":"2012","unstructured":"Kanaan NM, Manfredsson FP (2012) Loss of functional alpha-synuclein: a toxic event in Parkinson\u2019s disease? J Parkinsons Dis 2(4):249\u2013267","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"12734_CR41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13195-021-00786-8","volume":"13","author":"A Surendranathan","year":"2021","unstructured":"Surendranathan A et al (2021) Introduction of an assessment toolkit associated with increased rate of DLB diagnosis. Alzheimers Res Ther 13(1):50","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"12734_CR42","volume":"13","author":"F D'Antonio","year":"2021","unstructured":"D\u2019Antonio F et al (2021) Dementia with Lewy bodies research consortia: a global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working group. Alzheimers Dement (Amst) 13(1):e12235","journal-title":"Alzheimers Dement (Amst)"},{"issue":"7","key":"12734_CR43","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp-2020-325668","volume":"92","author":"E Bayram","year":"2021","unstructured":"Bayram E et al (2021) Sex differences for phenotype in pathologically defined dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 92(7):745\u2013750","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"12734_CR44","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL (2016) Sex differences in immune responses. Nat Rev Immunol 16(10):626\u2013638","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"12734_CR45","doi-asserted-by":"crossref","first-page":"e1031","DOI":"10.1212\/WNL.0000000000012450","volume":"97","author":"E Matar","year":"2021","unstructured":"Matar E et al (2021) Progression of clinical features in Lewy body dementia can be detected over 6 months. Neurology 97(10):e1031\u2013e1040","journal-title":"Neurology"},{"issue":"1","key":"12734_CR46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41531-023-00585-y","volume":"9","author":"C Moreau","year":"2023","unstructured":"Moreau C et al (2023) Overview on wearable sensors for the management of Parkinson\u2019s disease. NPJ Parkinsons Dis 9(1):153","journal-title":"NPJ Parkinsons Dis"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12734-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12734-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12734-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T18:00:23Z","timestamp":1738173623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12734-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["12734"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12734-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,12]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"43"}}